Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) EPS (Weighted Average and Diluted) (2021 - 2025)

CorMedix (CRMD) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with $0.07 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 70.83% to $0.07 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.91 through Dec 2025, up 716.13% year-over-year, with the annual reading at $2.04 for FY2025, 780.0% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $0.07 in Q4 2025 for CorMedix, down from $1.26 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.26 in Q3 2025 to a low of -$0.26 in Q4 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged $0.06 across 5 years, with a median of $0.01 in 2024.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 230.95% in 2023 and later soared 2620.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.26 in 2021, then grew by 20.58% to -$0.2 in 2022, then increased by 16.6% to -$0.17 in 2023, then soared by 241.18% to $0.24 in 2024, then tumbled by 70.83% to $0.07 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CRMD at $0.07 in Q4 2025, $1.26 in Q3 2025, and $0.28 in Q2 2025.